PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, The Second Hospital of Fuyang, Fuyang, 236015, China.\', \'Department of Infectious Diseases, The Second Hospital of Anhui Medical University, Furong Road 678, Hefei, 230601, China.\', \'Institute of Clinical Virology, The Second Hospital of Anhui Medical University, Hefei, 230601, China.\', \'Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany.\', \'Department of Infectious Diseases, West German Centre of Infectious Diseases, University Hospital of Essen, University of Duisburg-Essen, 45147, Essen, Germany.\', \'Institute for Virology, University Hospital of Essen, University of Duisburg-Essen, Hufelandstrasse 55, 45147, Essen, Germany. mengji.lu@uni-due.de.\', \'Department of Infectious Diseases, The Second Hospital of Anhui Medical University, Furong Road 678, Hefei, 230601, China. zzh1974cn@163.com.\', \'Institute of Clinical Virology, The Second Hospital of Anhui Medical University, Hefei, 230601, China. zzh1974cn@163.com.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1007/s00430-020-00693-z
?:doi
?:hasPublicationType
?:journal
  • Medical microbiology and immunology
is ?:pmid of
?:pmid
?:pmid
  • 32860073
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.287
?:rankingScore_hIndex
  • 52
is ?:relation_isRelatedTo_publication of
?:title
  • Assessing SARS-CoV-2 RNA levels and lymphocyte/T cell counts in COVID-19 patients revealed initial immune status as a major determinant of disease severity.
?:type
?:year
  • 2020

Metadata

Anon_0  
expand all